Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-18-038823
Filing Date
2018-12-20
Accepted
2018-12-20 15:05:12
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 32023
2 filename2.txt TEXT-EXTRACT 1192
  Complete submission text file 0000000000-18-038823.txt   46324
Mailing Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Filed for) CIK: 0001348911 (see all company filings)

EIN.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations